StockData
Astrana Health, Inc. logo

Astrana Health, Inc. (ASTH) stock

ASTHNasdaqServices-Management Consulting ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/307% below fair value
$31.80+0.03 (+0.09%)

Close on Nov 13, 2026Market cap $1.77BP/E 29.7Yield –

Earnings

Astrana Health's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 1, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$1.02B
+7.1% on a year earlier
Adjusted EPS - diluted, Q3 FY2026
$0.71
$0.01 a year earlier
Latest guidance
Issued
Nov 5, 2026 · 5 items

Quarterly results

Revenue and earnings per share from each of Astrana Health's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Mar 1, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026after the close$1.02B+7.1%$0.26$0.71Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026after the close$972.50M+48.5%$0.40$0.80Release
Q1 FY2026ended Mar 31, 2026May 7, 2026after the close$965.10M+55.6%$0.29$0.74Release
Q4 FY2025ended Dec 31, 2025Mar 2, 2026before the open$950.50M+42.9%$0.12$0.54Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025after the close$956.00M+99.7%$0.01–Release
Q2 FY2025ended Jun 30, 2025Aug 7, 2025after the close$654.80M+34.6%$0.19–Release
Q1 FY2025ended Mar 31, 2025May 8, 2025after the close$620.40M+53.4%$0.14–Release
Q4 FY2024ended Dec 31, 2024Feb 27, 2025after the close$665.20M+88.4%-$0.15–Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024after the close$478.70M+37.5%$0.33–Release
Q2 FY2024ended Jun 30, 2024Aug 7, 2024after the close$486.30M+39.7%$0.40–Release
Q1 FY2024ended Mar 31, 2024May 7, 2024after the close$404.40M+19.9%$0.31–Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Astrana Health's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Total revenueGAAPQ4 FY2026$939.00M – $1.04B–NewNov 5, 2026
Adjusted EBITDAnon-GAAPQ4 FY2026$48.50M – $61.50M–NewNov 5, 2026
Total revenueGAAPFY2026$3.90B – $4.00B–NewNov 5, 2026
Total revenueFY2026$3.80B – $4.10B–NewMay 7, 2026
Adjusted EBITDAnon-GAAPFY2026$261.00M – $274.00M–NewNov 5, 2026
Adjusted EBITDAnon-GAAPFY2026$250.00M – $280.00M$208.00M – $238.00MRaisedMay 7, 2026
Free cash flownon-GAAPFY2026$107.50M – $130.00M–NewNov 5, 2026
Free cash flownon-GAAPFY2026$105.00M – $132.50M$105.00M – $132.50MReaffirmedAug 6, 2026
Net incomeGAAPFY2026$54.00M – $74.00M–NewMar 2, 2026

Guidance vs results

The last range Astrana Health gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
Q3 FY2026Revenue$1.00B – $1.03B$1.02BWithin range
Q2 FY2026Revenue$965.00M – $1.00B$972.50MWithin range
FY2025Revenue$3.10B – $3.18B$3.18BΣ4QAbove range
Q3 FY2025Revenue$925.00M – $965.00M$956.00MWithin range
Q2 FY2025Revenue$615.00M – $655.00M$654.80MWithin range

Guidance history

Every forecast Astrana Health put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 5, 2026Adjusted EBITDAFY2026$261.00M – $274.00MNew
Nov 5, 2026Adjusted EBITDAQ4 FY2026$48.50M – $61.50MNew
Nov 5, 2026Free cash flowFY2026$107.50M – $130.00MNew
Nov 5, 2026Total revenueFY2026$3.90B – $4.00BNew
Nov 5, 2026Total revenueQ4 FY2026$939.00M – $1.04BNew
Aug 6, 2026Adjusted EBITDAQ3 FY2026$72.50M – $77.50MNew
Aug 6, 2026Free cash flowFY2026$105.00M – $132.50MReaffirmed
Aug 6, 2026Total revenueQ3 FY2026$1.00B – $1.03BNew
May 7, 2026Adjusted EBITDAFY2026$250.00M – $280.00MRaised
May 7, 2026Adjusted EBITDAQ2 FY2026$65.00M – $70.00MNew
May 7, 2026Free cash flowFY2026$105.00M – $132.50MNew
May 7, 2026Total revenueFY2026$3.80B – $4.10BNew
May 7, 2026Total revenueQ2 FY2026$965.00M – $1.00BNew
Mar 2, 2026EBITDAFY2026$208.00M – $238.00MNew
Mar 2, 2026Net incomeFY2026$54.00M – $74.00MNew
Nov 6, 2025Adjusted EBITDAFY2025$200.00M – $210.00MNew
Nov 6, 2025Total revenueFY2025$3.10B – $3.18BNew
Aug 7, 2025Adjusted EBITDAQ3 FY2025$65.00M – $70.00MNew
Aug 7, 2025Adjusted EBITDAFY2025$215.00M – $225.00MReaffirmed
Aug 7, 2025Total revenueFY2025$3.10B – $3.30BNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Astrana Health filed with the SEC as exhibits to Form 8-K or 6-K

  1. Astrana Health, Inc. Reports Third Quarter
    Results
  2. Third Quarter 2026 Earnings Supplement
    Results
  3. 8-K exhibit EX-99.1
    Update
  4. 8-K exhibit EX-99.1
    Update
  5. Astrana Health, Inc. Reports Second Quarter
    Results
  6. August 2026 Second Quarter 2026 Earnings Supplement
    Results
  7. Astrana Health ACOs Deliver $120.4
    Update
  8. 8-K exhibit EX-99.1
    Update
  9. Astrana Health, Inc. Reports First Quarter
    Results
  10. May 2026 First Quarter 2026 Earnings Supplement
    Results
  11. of June 30, 2025 and
    News
  12. UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT
    News
  13. 7 2025 2024 2023 2022 2021 2020 2019 16 11 6 6 4 3 3 # of Markets Astrana now serves sixteen markets across the country Note: Colored states represent those with more than 5,000 members
    Update
  14. Astrana Health, Inc. Reports Fourth Quarter
    Results
  15. March 2026 Fourth Quarter & Full Year 2025 Earnings Supplement
    Results

See a number that looks wrong?